Pharmaceutics product development scientists are at the forefront of creating new pharmaceutical formulations that meet both therapeutic goals and patient needs. Their primary responsibility is to design drug products that deliver active pharmaceutical ingredients effectively and safely. This involves selecting the right combination of excipients, optimizing dosage forms, and improving drug stability and bioavailability. They use a variety of formulation techniques to develop products such as tablets, capsules, injectables, and novel delivery systems like transdermal patches or nanoparticle-based carriers. By conducting extensive preformulation and formulation studies, these scientists ensure the drug’s effectiveness while minimizing side effects and maximizing patient compliance.
Moreover, pharmaceutics product development scientists play a critical role in the entire product lifecycle, from initial concept to commercial production. They collaborate with analytical scientists, regulatory experts, and manufacturing teams to ensure that products meet quality standards and regulatory requirements. Their work often includes performing stability testing, compatibility studies, and scale-up processes to ensure that laboratory formulations can be produced consistently on an industrial scale. With ongoing advancements in drug delivery technologies and personalized medicine, these scientists continue to innovate, developing safer, more effective pharmaceutical products that address complex medical challenges and improve global health outcomes. Their contributions are essential to bringing new and improved therapies to patients worldwide.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia